ResearcherLyon 1 UniversitéNo recent work listed
Charles Dumontet
Matched on ORCID iD 0000-0003-1875-134X; OpenAlex author ID A5006793451. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2012: 1 paper · 2013: 1 paper
Papers 2
- Do hENT1 and RRM1 predict the clinical benefit of gemcitabine in pancreatic cancer? First author DOI 10.2217/bmm.13.48↗
- Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinoma. Co-author DOI 10.1053/j.gastro.2012.06.006↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lars Petter Jordheim · 2 shared papers, 2012–2013 · strength 0.10
- Raphaël Maréchal · 1 shared paper, 2012 · strength 0.02
- Philippe R Rougier · 1 shared paper, 2012 · strength 0.02
- Jean Closset · 1 shared paper, 2012 · strength 0.02
- Pieter Demetter · 1 shared paper, 2012 · strength 0.02
- Magali Svrcek · 1 shared paper, 2012 · strength 0.02
- Jean‐Luc Van Laethem · 1 shared paper, 2012 · strength 0.02
- Anne Couvelard Benveniste · 1 shared paper, 2012 · strength 0.02
- François Paye · 1 shared paper, 2012 · strength 0.02
- Alain Sauvanet Sauvanet · 1 shared paper, 2012 · strength 0.02
- Jacques M.E. Deviere · 1 shared paper, 2012 · strength 0.02
- Thierry André · 1 shared paper, 2012 · strength 0.02
- Christophe Louvet · 1 shared paper, 2012 · strength 0.02
- Pascal R. Hammel · 1 shared paper, 2012 · strength 0.02
- Jean‐Baptiste Bachet · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.